rs8137674

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002473.6(MYH9):​c.2038-5T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00188 in 1,612,922 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 23 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 20 hom. )

Consequence

MYH9
NM_002473.6 splice_region, intron

Scores

2
Splicing: ADA: 0.00007252
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0450

Publications

6 publications found
Variant links:
Genes affected
MYH9 (HGNC:7579): (myosin heavy chain 9) This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
MYH9 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • May-Hegglin anomaly
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 22-36306056-A-G is Benign according to our data. Variant chr22-36306056-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 44553.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00807 (1229/152310) while in subpopulation AFR AF = 0.0267 (1111/41546). AF 95% confidence interval is 0.0254. There are 23 homozygotes in GnomAd4. There are 574 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1229 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002473.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH9
NM_002473.6
MANE Select
c.2038-5T>C
splice_region intron
N/ANP_002464.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH9
ENST00000216181.11
TSL:1 MANE Select
c.2038-5T>C
splice_region intron
N/AENSP00000216181.6
MYH9
ENST00000685801.1
c.2101-5T>C
splice_region intron
N/AENSP00000510688.1
MYH9
ENST00000955568.1
c.2101-5T>C
splice_region intron
N/AENSP00000625627.1

Frequencies

GnomAD3 genomes
AF:
0.00805
AC:
1225
AN:
152192
Hom.:
23
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0267
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00281
Gnomad ASJ
AF:
0.00979
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00279
AC:
700
AN:
250642
AF XY:
0.00228
show subpopulations
Gnomad AFR exome
AF:
0.0266
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.0131
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000424
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00124
AC:
1804
AN:
1460612
Hom.:
20
Cov.:
32
AF XY:
0.00113
AC XY:
824
AN XY:
726644
show subpopulations
African (AFR)
AF:
0.0268
AC:
897
AN:
33476
American (AMR)
AF:
0.00246
AC:
110
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0116
AC:
303
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52204
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.000236
AC:
262
AN:
1111984
Other (OTH)
AF:
0.00356
AC:
215
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
112
224
336
448
560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00807
AC:
1229
AN:
152310
Hom.:
23
Cov.:
33
AF XY:
0.00771
AC XY:
574
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0267
AC:
1111
AN:
41546
American (AMR)
AF:
0.00274
AC:
42
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00979
AC:
34
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68030
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
61
122
184
245
306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00548
Hom.:
4
Bravo
AF:
0.00928
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.000652

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Autosomal dominant nonsyndromic hearing loss 17 (1)
-
-
1
Autosomal dominant nonsyndromic hearing loss 17;C5200934:Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (1)
-
-
1
Kidney disorder (1)
-
-
1
MYH9-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.51
DANN
Benign
0.65
PhyloP100
-0.045
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000073
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8137674; hg19: chr22-36702102; API